Karyopharm Therapeutics
KPTI
KPTI
103 hedge funds and large institutions have $306M invested in Karyopharm Therapeutics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
5% less funds holding
Funds holding: 108 → 103 (-5)
Holders
103
Holding in Top 10
–
Calls
$4.58M
Puts
$815K
Top Buyers
| 1 | +$18.9M | |
| 2 | +$15.6M | |
| 3 | +$3.86M | |
| 4 |
AI
Atom Investors
Austin,
Texas
|
+$2.52M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.31M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$5.46M | |
| 3 | -$5.06M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.91M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.97M |